カタログ製品コード : C-E0093h
ELISA kit for C-C motif chemokine 4
24T | ¥75,600 | (¥3,150/T) (税別) |
48T | ¥86,500 | (¥1,802/T) (税別) |
96T | ¥102,800 | (¥1,071/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-E0093h
ELISA kit for C-C motif chemokine 4
24T | ¥75,600 | (¥3,150/T) (税別) |
48T | ¥86,500 | (¥1,802/T) (税別) |
96T | ¥102,800 | (¥1,071/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
EIAab | CCL4 | Human | 15.6-1000 pg/mL | 100 μl | 血清、血漿、尿、組織ホモジネート、細胞培養上清等 |
■保存方法 :
一時保存の場合
TMB:4℃
試薬類:バイアルに記載の温度
長期保存の場合
-20℃
■測定原理 :
The microtiter plate provided in this kit has been pre-coated with an antibody specific to . Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated polyclonal antibody preparation specific for and Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain , biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of in the samples is then determined by comparing the O.D. of the samples to the standard curve.
■構成内容 :
Reagent | Quantity |
Assay plate | 1 |
Standard | 2 |
Sample Diluent | 1 × 20ml |
Assay Diluent A | 1 × 10ml |
Assay Diluent B | 1 × 10ml |
Detection Reagent A | 1 × 120μl |
Detection Reagent B | 1 × 120μl |
Wash Buffer(25 x concentrate) | 1 × 30ml |
Substrate | 1 × 10ml |
Stop Solution | 1 × 10ml |
Plate sealer for 96 wells | 5 |
Instruction | 1 |
■キーワード :
Homo sapiens,Human,C-C motif chemokine 4,G-26 T-lymphocyte-secreted protein,HC21,Lymphocyte activation gene 1 protein,LAG-1,MIP-1-beta(1-69),Macrophage inflammatory protein 1-beta,MIP-1-beta,PAT
■ターゲット情報 :
Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B.